Because Creative Commons lists only version 3 of the GNU GPL on its compatible licenses list, it means that you can not license your adapted CC BY-SA works under the terms of “GNU GPL version 3, or (at your option) any later version.” However, Section 14 of the GNU GPL version 3 allows licensors to specify a proxy to determine whether future versions of the GNU GPL can be used. Therefore, if someone adapts a CC BY-SA work and incorporates it into a GNU GPL version 3 licensed project, they can specify Creative Commons as their proxy (via http:///compatiblelicenses ) so that if and when Creative Commons determines that a future version of the GNU GPL is a compatible license, the adapted and combined work could be used under that later version of the GNU GPL.
There is at the present time no management plan sensu stricto for the walls in operation in Lugo: work is continuing on the basis of the 1992 plan. Nor is there a technical unit specifically responsible for the conservation and restoration of the walls. It is against this background that serious consideration is being given to the creation of an independent foundation, under royal patronage and with representatives from government, academic, voluntary, and business institutions, to work with the General Directorate of Cultural Heritage of Galicia. The work plan of this body would include the development and implementation of integrated conservation, restoration, and maintenance programmes.
The list was developed in collaboration with the Division of Infectious Diseases at the University of Tübingen, Germany, using a multi-criteria decision analysis technique vetted by a group of international experts. The criteria for selecting pathogens on the list were: how deadly the infections they cause are; whether their treatment requires long hospital stays; how frequently they are resistant to existing antibiotics when people in communities catch them; how easily they spread between animals, from animals to humans, and from person to person; whether they can be prevented (. through good hygiene and vaccination); how many treatment options remain; and whether new antibiotics to treat them are already in the R&D pipeline.